Latest News

October 15, 2024

Cooperative Groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

October 11, 2024

Journal of Clinical Oncology publishes RTOG 1106/ACRIN 6697 results: Midtreatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients

October 11, 2024

Mid-treatment PET-adapted radiotherapy dose escalation fails to improve outcomes for lung cancer patients: Results of NRG-RTOG1106/ECOG-ACRIN 6697

October 10, 2024

Women in Medicine Month: Celebrating Women Advancing Radiology

September 26, 2024

The Fall 2024 advocacy blog Considering Clinical Trials is now available

September 20, 2024

The September 2024 News from ECOG-ACRIN blog is now available

September 18, 2024

Press Release: Cancer Cooperative Group leaders propose a re-engineering of the nationā€™s correlative science program for cancer

September 10, 2024

Press Release: Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

September 6, 2024

Attention APPs: Travel funds are available for the Fall 2024 Group Meeting (apply now)


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
46

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group